Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Bochum, North Rhine-Westphalia, 44791, Germany
NCT Number: NCT01498250
Perturbations in microRNA (miRNA) expression profiles has been reported for a variety of cancers. This study will be an exploratory analysis of miRNA expression in basal cell carcinoma by miRNA expression profiling using microarrays.
Looking for future studies?
Notify Me1 year and older
All sexes
Observational
Bochum, North Rhine-Westphalia, 44791, Germany
Perturbations in the expression profiles of microRNAs (miRNAs) have been reported for a variety of different cancers. Basal cell carcinoma (BCC) of the skin has not been systematically evaluated regarding differentially expressed miRNAs. Patients with BCC are included in the study to perform an exploratory analysis by miRNA expression profiling using microarrays. Expression levels of miRNA candidates will be validated by TaqMan real-time quantitative polymerase chain reaction (RT-PCR).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ruhr University of Bochum
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04552990
BCC, BCC - Basal Cell Carcinoma
New York, United States
View Trial DetailsNCT00833417
Basal Cell Carcinoma, Carcinoma
Scottsdale, Arizona, United States
View Trial DetailsNCT00959647
Adnexal Diseases, Basal Cell Carcinoma
Scottsdale, Arizona, United States
View Trial DetailsNCT02667574
Basal Cell Carcinoma, Carcinoma
Besançon, France
View Trial Details